Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Ning J et al. | 1992 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), Daudi (Burkitt's lymphoma cell line) cells and normal human lymphocytes | low frequency, signals/pulses, 50/60 Hz, magnetic field | 0.1 mT |
Masiuk M et al. | 2008 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), K-562 (chronic myelogenous leukemia) | magnetic field, 50/60 Hz | 10–20 mT |
Jin M et al. | 1997 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), two different populations: Columbia University Cancer Center (CUCC), American Type Culture Collection (ATCC) | magnetic field, 50/60 Hz | 8 µT |
Lin H et al. | 1998 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells), MCF-7, T-47D, and HTB-124 cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz | 8 µT |
Lacy-Hulbert A et al. | 1995 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 0.1–100 µT |
Greene JJ et al. | 1991 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | electric field, magnetic field, 50/60 Hz | 1 mT |
Pipkin JL et al. | 1999 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 100 µT–1 mT |
Greene JJ et al. | 1993 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 1 mT |
Balcer-Kubiczek EK et al. | 2000 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
Lin H et al. | 1995 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 6.7 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.